Instrument Inactif

Autres langues Adherex Technologies Inc. (USA) Other OTC

Actions

CA00686R4089

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

15/05	FENNEC PHARMACEUTICALS INC. : HC Wainwright reste à l'achat	ZM
14/05	Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

FENNEC PHARMACEUTICALS INC. : HC Wainwright reste à l'achat	15/05
Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024	14/05
Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue	14/05
Fennec Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing	23/04
Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing	19/04
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing	17/04
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing	05/04
FENNEC PHARMACEUTICALS INC. : HC Wainwright favorable sur le dossier	04/04
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing	03/04
Transcript : Fennec Pharmaceuticals Inc., 2023 Earnings Call, Mar 21, 2024	21/03
Fennec Pharmaceuticals up 3.2% in US Premarket, Reports Narrower Q4 Loss of $0.10 Per Share	21/03
Fennec Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Fennec Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
Sector Update: Health Care Stocks Steady Premarket Monday	18/03
Sector Update: Health Care	18/03
Fennec Pharmaceuticals Inc. and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand	18/03
Fennec Pharmaceuticals Inc. Provides Unaudited Earnings Guidance for the Fourth Quarter and Full Year of 2023	29/02
Fennec Pharmaceuticals Inc. Announces U.S. Food and Drug Administration Issues Reminder of Non-Substitution of PEDMARK®? (Sodium Thiosulfate Injection) for Pediatric Patients Receiving Cisplatin	01/02
Wedbush Reviews Fennec Pharmaceuticals' Q3 Results	06/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Adherex Technologies Inc. (USA) Other OTC

Actions

CA00686R4089

Autres langues

Filtres